DCE-MRI Deep Learning for Low-Dose BBB Opening Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical imaging techniques using gadolinium-based contrast agents (GBCAs) for detecting blood-brain barrier (BBB) openings face issues such as retention in body tissues, increased scanning time, and patient discomfort, necessitating a reduction in GBCA dosage while maintaining accurate detection.
Innovation Solution
Employing deep learning models, specifically spatiotemporal networks like ST-Net, to analyze dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scans, extracting spatial and temporal information to form Ktrans maps, reducing the need for high GBCA doses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If gadolinium-based contrast agents (GBCAs) are used for detecting BBB openings, then detection accuracy is improved, but agent retention in body tissues increases
Solution Approach 1:
The patent introduces deep learning models as an intermediary computational system that processes DCE-MRI data to detect BBB openings. This mediator enables accurate detection without requiring high concentrations of GBCA, as the AI model extracts meaningful patterns from the imaging data, reducing the need for large amounts of contrast agent and thereby minimizing agent retention in tissues.
Solution Approach 2:
The patent changes the detection parameters by using deep learning-based analysis of DCE-MRI data instead of traditional contrast-based detection methods. This parameter change allows for reduced GBCA dosage while maintaining detection accuracy, as the deep learning model can detect BBB openings by analyzing temporal and spatial patterns in the imaging data rather than relying solely on contrast enhancement.
2Measurement precision
If contrast-based sequences are used for BBB opening detection, then detection capability is improved, but MRI scanning time is extended
Solution Approach 1:
The patent extracts the essential detection function from the contrast-based imaging sequences and isolates it into a deep learning analysis module. By separating the detection capability from the time-consuming contrast sequences, the system can use optimized DCE-MRI protocols with reduced scanning time while maintaining detection capability through the AI model's ability to process and analyze the extracted imaging data efficiently.
Solution Approach 2:
The patent replaces the mechanical contrast-based detection mechanism with a computational deep learning system. Instead of relying on physical contrast agents and extended imaging sequences, the system uses algorithms to detect BBB openings from DCE-MRI data, substituting mechanical imaging processes with computational analysis that reduces scanning time while preserving detection capability.
3Measurement precision
If high dosage of GBCA is administered, then detection accuracy is improved, but patient discomfort and motion artifacts increase
Solution Approach 1:
The patent applies partial action by using deep learning analysis to achieve accurate detection with only a portion of the contrast agent dosage that would traditionally be required. The AI model compensates for the reduced contrast enhancement by extracting subtle patterns from the DCE-MRI data, enabling accurate BBB opening detection with lower GBCA doses and thereby reducing patient discomfort and associated motion artifacts.
Data Source
AI summary
The subject matter includes systems and methods for a deep learning technique applied to dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) scans. The disclosed aims to reduce the dosage of gadolinium-based contrast agents (GBCAs) while maintaining accurate detection and enhancement of BBB openings. A spatiotemporal network (ST-Net) is introduced, combining spatial and temporal networks, allowing for the extraction of diagnostic quality images with reduced GBCAs dosage.